Prime Healthcare Foundation has reached an agreement to acquire Central Maine Healthcare, enhancing local healthcare resources and committing $150 million to facility upgrades over the next five years.

Information on the Target

Central Maine Healthcare (CMH) is a comprehensive healthcare system dedicated to providing a wide range of medical services to the population of Central Maine. The network includes several key facilities: Central Maine Medical Center, Bridgton Hospital, Rumford Hospital, and Rumford Community Home, along with the Maine College of Health Professions and the CMH Cancer Care Center. Additionally, the system encompasses over 40 physician practices. This robust structure aims to meet various healthcare needs in the region, from emergency medical care to cancer treatment and community health initiatives. The acquisition by Prime Healthcare Foundation is expected to close by the end of 2025, pending regulatory approvals.

Industry Overview in the Target's Specific Country

The healthcare industry in the United States faces numerous challenges, including rising costs, an aging population, and disparities in access to quality care. In particular, rural areas like Central Maine often struggle to maintain adequate healthcare resources, leading to efforts aimed at improving infrastructure and services. The demand for healthcare services continues to rise, necessitating innovative solutions to provide efficient and accessible care to vulnerable communities.

Moreover, the COVID-19 pandemic has amplified existing issues in the U.S. healthcare system, such as workforce shortages and increased patient loads. Hospitals and healthcare systems are now focusing on enhancing their operational efficiency and invest

View Source

Similar Deals

AbbVie Capsida Biotherapeutics

2025

Corporate VC Bio Therapeutic Drugs United States of America
Faraday Future Intelligent Electric Inc. Qualigen Therapeutics, Inc.

2025

Corporate VC Bio Therapeutic Drugs United States of America
Scilex Holding Company Datavault AI Inc.

2025

Corporate VC Proprietary & Advanced Pharmaceuticals United States of America
Carlyle Kidney Care business

2025

Corporate VC Advanced Medical Equipment & Technology (NEC) United States of America
Spur SwanBio Therapeutics

2024

Corporate VC Bio Therapeutic Drugs United States of America
Pieris Pharmaceuticals, Inc. Palvella Therapeutics, Inc.

2024

Corporate VC Proprietary & Advanced Pharmaceuticals United States of America

Prime Healthcare Foundation

invested in

Central Maine Healthcare

in 2025

in a Corporate VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert